Literature DB >> 7952889

Loss of preconditioning in rabbits with vascular tolerance to nitroglycerin.

Z Szilvassy1, P Ferdinandy, P Bor, I Jakab, J Szilvassy, I Nagy, J Lonovics, M Koltai.   

Abstract

A preceding right ventricular overdrive pacing (VOP) of 500 b.p.m. for 5 min, markedly reduced the severity of global myocardial ischaemia produced by a subsequent 5-min VOP in conscious rabbits. This VOP-induced preconditioning developed in parallel with an increase in cardiac cyclic guanosine 3':5'-monophosphate (cyclic GMP) content. VOP-induced preconditioning was abolished when the animals had been made tolerant to the vasodilator effect of nitroglycerin (NG). In the heart of the NG-tolerant rabbits, neither VOP nor preconditioning increased cyclic GMP content. This suggests that changes by NG tolerance of cyclic GMP metabolism may account for the loss of VOP-induced preconditioning.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952889      PMCID: PMC1910237          DOI: 10.1111/j.1476-5381.1994.tb13180.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover.

Authors:  K L Axelsson; R G Andersson
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

Review 3.  Nitrate tolerance from a biochemical point of view.

Authors:  K L Axelsson; J Ahlner
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.

Authors:  A Vegh; J G Papp; L Szekeres; J R Parratt
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits.

Authors:  Z Szilvassy; I Jakab; P Ferdinandy; M Koltai; J Lonovics; T Tarrade; P G Braquet
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

6.  Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle.

Authors:  R A Keith; A M Burkman; T D Sokoloski; R H Fertel
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

7.  Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.

Authors:  A Vegh; L Szekeres; J Parratt
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

8.  Cicletanine attenuates overdrive pacing-induced global myocardial ischemia in rabbits: possible role of cardiac cyclic nucleotides.

Authors:  Z Szilvassy; I Jakab; P Bor; M Koltai; T Tarrade; A Esanu; P G Braquet; J Lonovics
Journal:  Coron Artery Dis       Date:  1993-05       Impact factor: 1.439

  8 in total
  5 in total

1.  Insulin sensitization induced by oral cicletanine in conscious rabbits.

Authors:  Barna Peitl; József Németh; Csaba Pankucsi; Zoltán Szilvássy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-06       Impact factor: 3.000

2.  Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP.

Authors:  T Csont; Z Szilvássy; F Fülöp; S Nedeianu; T Páli; A Tosaki; L Dux; P Ferdinandy
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin.

Authors:  P Ferdinandy; Z Szilvássy; T Csont; C Csonka; E Nagy; M Koltai; L Dux
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide.

Authors:  P Ferdinandy; C Csonka; T Csont; Z Szilvássy; L Dux
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

5.  Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease.

Authors:  Daniel Priksz; Mariann Bombicz; Balazs Varga; Andrea Kurucz; Rudolf Gesztelyi; Jozsef Balla; Attila Toth; Zoltan Papp; Zoltan Szilvassy; Bela Juhasz
Journal:  Int J Mol Sci       Date:  2018-09-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.